SAM
Simplify Asset Management Portfolio holdings
AUM
$1.65B
This Quarter Return
+5.97%
1 Year Return
+8.73%
3 Year Return
+37.73%
5 Year Return
–
10 Year Return
–
AUM
$1.65B
AUM Growth
-$492M
(-23%)
Cap. Flow
-$582M
Cap. Flow
% of AUM
-35.28%
Top 10 Holdings %
Top 10 Hldgs %
88.92%
Holding
110
New
15
Increased
16
Reduced
49
Closed
20
Top Buys
| 1 |
SBAR
Simplify Barrier Income ETF
SBAR
|
$28.8M |
| 2 |
XV
Simplify Target 15 Distribution ETF
XV
|
$26.6M |
| 3 |
National Vision
EYE
|
$6.47M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
$6.2M |
| 5 |
GeneDx Holdings
WGS
|
$5.23M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$488M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
$55.9M |
| 3 |
Simplify High Yield ETF
CDX
|
$29.8M |
| 4 |
Simplify US Equity PLUS Upside Convexity ETF
SPUC
|
$18.8M |
| 5 |
Simplify Intermediate Term Treasury Futures Strategy ETF
TYA
|
$12.5M |
Sector Composition
| 1 | Healthcare | 7.83% |
| 2 | Energy | 1.5% |
| 3 | Consumer Discretionary | 0.88% |
| 4 | Industrials | 0.66% |
| 5 | Consumer Staples | 0.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Guardant Health
GH
$8.11B
| $1.39M | 0.07% |
+26,631
| New | +$1.39M |
|
52
Biohaven
BHVN
$1.71B
| $1.36M | 0.07% |
+96,389
| New | +$1.36M |
|
53
Nektar Therapeutics
NKTR
$543M
| $1.34M | 0.07% |
+51,998
| New | +$1.34M |
|
54
Abbott
ABT
$230B
| $1.33M | 0.07% |
9,794
-1,064
| -10% | -$145K |
|
55
Zevra Therapeutics
ZVRA
$501M
| $1.3M | 0.07% |
147,000
+27,000
| +23% | +$238K |
|
56
UnitedHealth
UNH
$279B
| $1.26M | 0.06% |
4,051
-9,376
| -70% | -$2.93M |
|
57
IQVIA
IQV
$31.4B
| $1.25M | 0.06% |
+7,940
| New | +$1.25M |
|
58
Annaly Capital Management
NLY
$13.8B
| $1.18M | 0.06% |
62,900
-42,290
| -40% | -$796K |
|
59
Sanofi
SNY
$122B
| $1M | 0.05% |
20,716
-19,881
| -49% | -$960K |
|
60
Thermo Fisher Scientific
TMO
$183B
| $871K | 0.04% |
2,147
-6,923
| -76% | -$2.81M |
|
61
Benitec Biopharma
BNTC
$365M
| $809K | 0.04% |
69,173
-7,562
| -10% | -$88.5K |
|
62
argenx
ARGX
$44.2B
| $809K | 0.04% |
1,467
-152
| -9% | -$83.8K |
|
63
AGNC Investment
AGNC
$10.4B
| $790K | 0.04% |
86,000
-235,550
| -73% | -$2.16M |
|
64
Boston Scientific
BSX
$159B
| $763K | 0.04% |
+7,103
| New | +$763K |
|
65
EyePoint Pharmaceuticals
EYPT
$827M
| $748K | 0.04% |
79,472
-8,683
| -10% | -$81.7K |
|
|
CIM
66
Chimera Investment
CIM
$1.15B
| $708K | 0.04% |
51,025
-19,675
| -28% | -$273K |
|
67
Edwards Lifesciences
EW
$47.7B
| $691K | 0.03% |
8,830
-969
| -10% | -$75.8K |
|
68
Simplify Next Intangible Core Index ETF
NXTI
$27.3M
| $686K | 0.03% |
22,303
-3,522
| -14% | -$108K |
|
69
Ligand Pharmaceuticals
LGND
$3.25B
| $679K | 0.03% |
5,970
-646
| -10% | -$73.4K |
|
|
TWO
70
Two Harbors Investment
TWO
$1.05B
| $574K | 0.03% |
53,250
+22,250
| +72% | +$240K |
|
71
Ultragenyx Pharmaceutical
RARE
$3.04B
| $553K | 0.03% |
15,210
-1,690
| -10% | -$61.4K |
|
72
Cigna
CI
$80.2B
| $510K | 0.03% |
1,544
-19,815
| -93% | -$6.55M |
|
73
Fulcrum Therapeutics
FULC
$353M
| $503K | 0.03% |
73,154
-7,980
| -10% | -$54.9K |
|
74
Vertex Pharmaceuticals
VRTX
$102B
| $481K | 0.02% |
1,081
-114
| -10% | -$50.8K |
|
75
Athira Pharma
ATHA
$15.5M
| $451K | 0.02% |
1,492,792
| – | – |
|